Agilent Technologies (A) Shares are Down -0.63%

Agilent Technologies (A) has been under a strong bear grip, hence the stock is down -1.44% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 0.03% in the past 1 week. The 4-week change in the price of the stock is -1.64% and the stock has fallen -0.63% in the past 1 week.

For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a twenty day Moving Average of 0.58% and the fifty day Moving Average is 1.96%. Agilent Technologies, Inc. is up 3.55% in the last three month period. Year-to-Date the stock performance stands at 13.81%.

Agilent Technologies (A) : Currently there are 7 street experts covering Agilent Technologies (A) stock. The most bullish and bearish price target for the stock is $55 and $45 respectively for the short term. The average price target of all the analysts comes to $50.57. The estimated standard deviation from the target is $3.46.


Agilent Technologies (NYSE:A): stock turned positive on Friday. Though the stock opened at $47.41, the bulls momentum made the stock top out at $47.79 level for the day. The stock recorded a low of $47.07 and closed the trading day at $47.32, in the green by 0.13%. The total traded volume for the day was 1,581,245. The stock had closed at $47.26 in the previous days trading.

Agilent Technologies Inc. is engaged in the life sciences, diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business, the diagnostics and genomics business, and the Agilent CrossLab business. The Companys life sciences and applied markets business segment brings together the Companys analytical laboratory instrumentation and informatics. The Companys diagnostics and genomics business segment consists of three businesses: the Dako business, the genomics business and the nucleic acid solutions business. The Companys Agilent CrossLab business segment combines its analytical laboratory services and consumables business.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.